Suchen
PainReform Ltd
PRFXZur Watchlist hinzufügen
1.360USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
225.93KMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über PainReform Ltd Unternehmen
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PainReform Ltd Informationen
BörsenkürzelPRFX
Name des UnternehmensPainReform Ltd
IPO-datumSep 01, 2020
CEOHadar (Ilan)
Anzahl der mitarbeiter2
WertpapierartOrdinary Share
GeschäftsjahresendeSep 01
Addresse65 Yigal Alon St.
StadtTEL AVIV-YAFO
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl6744316
Telefon97237177051
Websitehttps://painreform.com/
BörsenkürzelPRFX
IPO-datumSep 01, 2020
CEOHadar (Ilan)
Führungskräfte von PainReform Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von PainReform Ltd?
Die fünf größten Anteilseigner von PainReform Ltd sind: Mr. Ilan Hadar
Wie viele Institutionen halten Anteile an PainReform Ltd (PRFX)?
Mit Stand vom 2026Q1 halten 16 Institutionen Anteile an PainReform Ltd, mit einem Gesamtmarktwert von etwa 15.73K, was 1.84% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4772.00 gestiegen.